Clinical Trial Update: Preoperative Alpha Blockade for Pheochromocytoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating preoperative alpha blockade for pheochromocytoma and paraganglioma has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Snippet

Sponsor: University of California, Los Angeles | Conditions: Pheochromocytoma, Paraganglioma | Phase 3 | Status: COMPLETED | Results posted: 2023-11-20